Trial
NCT05350163
T-cell Receptor α/β Depleted Donor Lymphocyte Infusion
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Guenther Koehne
Collaborators
—
Condition
Lymphoid Leukemia, Acute
Intervention
T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
Why stopped
The study met criteria for stopping due to lack of efficacy per protocol specifications.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-10